Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16621683 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL16621693 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL16621740 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL23138557 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL29442042 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL24794463 | 0.90 | TSPO (0.46) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL29442038 | 0.89 | ALDH1A1 (0.44) | TSPOALDH1A1MAPK1DNM1NR4A2 | |
| SCHEMBL21454045 | 0.89 | TSPO (0.45) | TSPOALDH1A1DNM1NPY5RNR4A2 | |
| SCHEMBL23814025 | 0.88 | ALDH1A1 (0.42) | TSPOALDH1A1MAPK1DNM1NR4A2 | |
| SCHEMBL23823892 | 0.87 | TSPO (0.44) | TSPOALDH1A1DNM1NPY5RNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118600-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
| US-20160118600-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118600-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CRY2 | TSPO 4512/4885ALDH1A1 142/4885MAPK1 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.